Haldar S - Search Results

1

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.

Reed JC, Cuddy M, Haldar S, Croce C, Nowell P, Makover D, Bradley K. Reed JC, et al. Among authors: haldar s. Proc Natl Acad Sci U S A. 1990 May;87(10):3660-4. doi: 10.1073/pnas.87.10.3660. Proc Natl Acad Sci U S A. 1990. PMID: 1692620 Free PMC article.

2

Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts.

Reed JC, Haldar S, Croce CM, Cuddy MP. Reed JC, et al. Among authors: haldar s. Mol Cell Biol. 1990 Aug;10(8):4370-4. doi: 10.1128/mcb.10.8.4370-4374.1990. Mol Cell Biol. 1990. PMID: 2196451 Free PMC article.

Although RAS proteins have long been known for their ability to bind and hydrolyze GTP, recent investigations suggest that BCL2 encodes a novel GTP-binding protein (S. Haldar, C. Beatty, Y. Tsujimoto, and C. M. Croce, Nature [London] 342:195-198, 1989). ...

Although RAS proteins have long been known for their ability to bind and hydrolyze GTP, recent investigations suggest that BCL2 encodes a no …

3

Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.

Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J. Reed JC, et al. Among authors: haldar s. Cancer Res. 1990 Oct 15;50(20):6565-70. Cancer Res. 1990. PMID: 2208117

4

Deregulated BCL2 expression enhances growth of a human B cell line.

Reed JC, Haldar S, Cuddy MP, Croce C, Makover D. Reed JC, et al. Among authors: haldar s. Oncogene. 1989 Sep;4(9):1123-7. Oncogene. 1989. PMID: 2789359

5

Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias.

Alnemri ES, Fernandes TF, Haldar S, Croce CM, Litwack G. Alnemri ES, et al. Among authors: haldar s. Cancer Res. 1992 Jan 15;52(2):491-5. Cancer Res. 1992. PMID: 1728422

6

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. Carson WE, et al. Among authors: haldar s. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7553-7. doi: 10.1073/pnas.91.16.7553. Proc Natl Acad Sci U S A. 1994. PMID: 7519782 Free PMC article.

7

Inactivation of Bcl-2 by phosphorylation.

Haldar S, Jena N, Croce CM. Haldar S, et al. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4507-11. doi: 10.1073/pnas.92.10.4507. Proc Natl Acad Sci U S A. 1995. PMID: 7753834 Free PMC article.

8

Purification and characterization of the bcl-2 protein.

Haldar S, Jena N, DuBois GC, Takayama S, Reed JC, Fu SS, Croce CM. Haldar S, et al. Arch Biochem Biophys. 1994 Dec;315(2):483-8. doi: 10.1006/abbi.1994.1529. Arch Biochem Biophys. 1994. PMID: 7986096

9

Down-regulation of bcl-2 by p53 in breast cancer cells.

Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Haldar S, et al. Cancer Res. 1994 Apr 15;54(8):2095-7. Cancer Res. 1994. PMID: 8174112

10

Bcl2 is the guardian of microtubule integrity.

Haldar S, Basu A, Croce CM. Haldar S, et al. Cancer Res. 1997 Jan 15;57(2):229-33. Cancer Res. 1997. PMID: 9000560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters